Efavirenz Has the Highest Anti-Proliferative Effect of Non-Nucleoside Reverse Transcriptase Inhibitors against Pancreatic Cancer Cells

@article{Hecht2015EfavirenzHT,
  title={Efavirenz Has the Highest Anti-Proliferative Effect of Non-Nucleoside Reverse Transcriptase Inhibitors against Pancreatic Cancer Cells},
  author={M. Hecht and Sonja Erber and T. Harrer and H. Klinker and T. Roth and H. Parsch and Nora Fiebig and R. Fietkau and L. Distel},
  journal={PLoS ONE},
  year={2015},
  volume={10}
}
  • M. Hecht, Sonja Erber, +6 authors L. Distel
  • Published 2015
  • Biology, Medicine
  • PLoS ONE
  • Background Cancer prevention and therapy in HIV-1-infected patients will play an important role in future. The non-nucleoside reverse transcriptase inhibitors (NNRTI) Efavirenz and Nevirapine are cytotoxic against cancer cells in vitro. As other NNRTIs have not been studied so far, all clinically used NNRTIs were tested and the in vitro toxic concentrations were compared to drug levels in patients to predict possible anti-cancer effects in vivo. Methods Cytotoxicity was studied by Annexin-V-APC… CONTINUE READING
    Induction of DNA damage and apoptosis in human leukemia cells by efavirenz.
    • 7
    LINE-1 as a therapeutic target for castration-resistant prostate cancer.
    • 4
    • PDF

    References

    Publications referenced by this paper.
    SHOWING 1-10 OF 65 REFERENCES